0
From the Archives Journals |

Sun Exposure, Sun Protection, and Vitamin D

June K. Robinson, MD
JAMA. 2005;294(12):1541-1543. doi:10.1001/jama.294.12.1541
Text Size: A A A
Published online

Objectives: To examine during what behaviors people apply sunscreen and to assess the relationship to UV exposure monitored by personal dosimetry and diaries.

Design: Open prospective observational study.

Setting: University hospital.

Participants: A convenience sample of 340 Danish volunteers: children, adolescents, indoor workers, sun worshippers, golfers, and gardeners (age range, 4-68 years).

Intervention: Subjects recorded sunscreen use and sun-exposure behavior in diaries and carried personal, electronic UV dosimeters, measuring time-stamped UV doses continuously, during a median of 119 days covering 346 sun-years (1 sun-year equals 1 subject participating during 1 summer season).

Main Outcome Measures: Associations between sunscreen use and age, sex, skin type, occupation, sunburn, UV exposure doses, and behavior; and adequate application density and sun protection factor required to prevent sunburn.

Results: There were great variations in sunscreen use, which was highly correlated with risk behavior (sunbathing or exposing the upper body) (r = 0.39; P<.001). Sunscreens were used on a median of 5 days per sun-year (range, 1 day for gardeners to 16 days for sun worshippers). Ten percent of females and 41% of males never used sunscreens. Females used sunscreens more but also had more unprotected risk behavior than males (8 days vs 4 days; P<.001). Sunscreen use was not correlated with age, and children had as much unprotected risk behavior as adults. Sunscreens were used on 86% of the days with risk behavior in southern Europe vs 20% in northern Europe (P<.001). The UV doses were significantly higher on days with sunscreen (P≤.03) and on sunburn days (P<.001). The median sun protection factor was 10.5. The sun-protecting effect corresponded to an application density of 0.5 mg/cm2.

Conclusions: Days with sunscreen correlated not with days without risk behavior, but with days “sunbathing with the intention to tan,” indicating that sunscreens were used as tanning aids to avoid sunburn.

Commentary

Despite using sun protection, many fair-skinned readers of this issue of JAMA experienced sunburn this summer. The personal experience of a tender sunburn makes it easy to identify with sun protection behaviors reported in the study published in the August issue of the Archives of Dermatology, in which Thieden et al1 measured UV exposure in conjunction with sunscreen use. Sunscreen use is correlated with high-risk activities such as gardening and deliberate sun exposure with intention to tan. While many individuals remember to use sunscreen when they expect to be exposed to the sun, most do not apply sunscreen every day, even though daily sunscreen use has been demonstrated to prevent squamous cell carcinoma.2

The study by Thieden et al1 resolves the conundrum between retrospective epidemiological studies and prospective studies of sunscreen use. Although more recent, controlled epidemiological studies have shown protective effects from sunscreen use,3 5 previous epidemiological studies of sunscreen use show increased skin cancer risk associated with sunscreen use.6 10 The early reports of association of sunscreen use with increased skin cancer risk was not supported by prospective controlled sunscreen trials, which have uniformly shown protection from sun-induced tumors.11 13 One explanation is that sunscreen use is sometimes a marker for those receiving larger short-wave UV doses that is not completely compensated for by the protective effect of sunscreen.

In this same issue of the Archives of Dermatology, Dupuy et al14 examined the effect of sunscreen labeling (sun protection factor [SPF]) among those at French vacation sites. Vacationers volunteered to be randomly assigned to 3 different sunscreen groups for a week during their holiday. Two groups were given SPF 40 sunscreen labeled either “basic protection” or “high protection,” but were blinded to the actual SPF number. The third group received SPF 12 labeled as “basic protection.” There was no difference in sunscreen use between the SPF 40 groups, suggesting that the “high protection” label did not lead to more intentional UV exposure or less sunscreen use than the same SPF 40 sunscreen labeled “basic protection.” Those who received SPF 12 sunscreen used more than those in the SPF 40 groups, which suggests that experiencing erythema may cause individuals to use more sunscreen. While sunscreens are not the method of choice for sun protection (avoidance and clothing are preferred), the policy of recommending a high SPF sunscreen is sound. The most common form of sun protection used is sunscreen. Usually, once the sunscreen is applied, the user forgets to reapply it or to limit the duration of sun exposure. Several national and international studies of sun exposure and sun protection behaviors showed that the amount of daily incidental sun exposure the average person receives is considerable.15 17

A recent health concern of some patients is that practicing sun protection may decrease intake of vitamin D. The benefits of vitamin D are well-known, including improved bone health, fracture prevention, better muscle health, and reduced risk of falling in older individuals. Recent widely reported epidemiological studies have shown a beneficial effect of vitamin D for colon cancer,18 multiple sclerosis,19 insulin resistance,20 21 osteoarthritis,22 hypertension,23 25 periodontal disease,26 and a variety of other cancers.27 28 Daily incidental sun exposure is adequate for vitamin D production to occur in fair-skinned individuals. Exposing 5% of the body surface in fair-skinned persons 2 to 3 times a week for 5 minutes of noontime summer sun exposure is equivalent to an intake of 430 IU/d of vitamin D, which satisfies the recommended vitamin D intake of 200 IU/d for young adults.29 Nonetheless, vitamin D deficiency does exist in healthy adolescents and has been reported in the winter months in both younger and older adults.30 For persons aged 51 to 70 years, the recommended vitamin D intake is 400 IU/d, and 600 IU/d for those older than 70 years.

While there is evidence that many individuals in the United States, particularly older adults and darker-skinned individuals, may have vitamin D levels lower than those necessary for optimum health, increasing exposure to either natural or artificial (UV) light is not recommended as a supplemental source of vitamin D.31 Vitamin D levels are lower in the elderly than in younger persons perhaps due to their thin epidermis having less 7-dehydrocholesterol, the source compound for the generation of vitamin D by suberythemal UV doses. The melanin pigment of the epidermis of darker-skinned individuals absorbs the UV photons responsible for the photochemical reactions producing pre-vitamin D. Photosynthesizing vitamin D through natural sunlight is maximized after 20 minutes of UV-B exposure. Extended sun exposure provides no additional benefit but does increase the likelihood of photo-related damage, skin cancer, and eye damage.

Sources of vitamin D that do not carry a risk of skin cancer are vitamin D supplements or food sources. Multivitamins usually contain 400 IU of vitamin D per tablet. In the United States, milk is supplemented and contains about 100 IU of vitamin D per 8-oz glass. One multivitamin tablet taken with a glass of milk provides 500 IU of vitamin D, which meets the current daily recommendations for those younger than 70 years.29 Some suggest that these recommendations may fail to bring most individuals up to the desired serum levels of 80 nmol/L. In particular, those who are lactose intolerant and consume less milk may need to take nutritional supplements of vitamin D and consume foods rich in vitamin D such as fatty fish (eg, salmon and mackerel). While supplements containing vitamin D and foods fortified with vitamin D can increase the serum levels, there are concerns about consistent compliance. Although supplements are inexpensive, they are not free and the population most at risk for vitamin D deficiency, darker-skinned individuals who are lactose intolerant, may be least able to afford them.

The recent increasing incidence of skin cancer, especially melanoma, is a cause for concern. Current estimates are that 1 in 5 individuals living in the United States will develop skin cancer during their lifetime. In 2005, it is estimated that 105 750 melanomas will be diagnosed in the United States: 59 580 invasive melanomas and 46 170 cases of melanoma in situ.32 Melanoma will claim about 7770 lives in 2005.33 One in 4 individuals who develop melanoma is younger than 40 years; and their death changes the lives of their young children. The direct cost of treating melanoma will exceed $563 million with most of the expense attributed to treating advanced stages.34

Physicians can help stem the tide of increasing incidence of melanoma by providing educational counseling about sun protection to those at greatest risk: the families of those with a history of skin cancer and those with fair skin that tans poorly and sunburns readily. Physician nonjudgmental counseling supports adopting sun protection to prevent unnecessary exposure to carcinogenic UV light by using the 4 sun protection recommendations: (1) avoidance of deliberate tanning with indoor or outdoor light, (2) seeking shade when outdoors, (3) wearing protective clothing such as a hat with a 4-inch brim, sunglasses, and a long-sleeved shirt whenever possible, and (4) applying a broad-spectrum sunscreen with an SPF of 15 or higher before going outdoors.35 36

In the United States, adolescents, particularly females, widely use indoor UV tanning and are particularly susceptible to discount pricing incentives.37 Physician leadership in state health departments should consider prohibiting youth discounts, particularly in states with indoor tanning youth access regulations. Parents and peers can be effective in leading individuals to reduce harmful behaviors.38

Corresponding Author: June K. Robinson, MD, Dartmouth-Hitchcock Medical Center, 1 Medical Center Dr, Lebanon, NH 03756 (archdermatol@jama-archives.org).

Disclaimer: Dr Robinson was not involved in the editorial evaluation or editorial decision to accept this work for publication.

REFERENCES

Thieden E, Philipsen PA, Sandby-Møller J, Wulf HC. Sunscreen use related to UV exposure, age, sex, and occupation based on personal dosimeter readings and sun-exposure behavior diaries.  Arch Dermatol. 2005;141967-973
PubMed
Green A, Williams G, Neale R.  et al.  Daily sunscreen application and betacarotene supplementation in prevention of basal cell and squamous cell carcinomas of the skin: a randomized controlled trial.  Lancet. 1999;354723-729
PubMed
Rodenas JM, Delgado-Rodriguez M, Herranz MT.  et al.  Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population.  Cancer Causes Control. 1996;7275-283
PubMed
Bakos L, Wagner M, Bakos RM.  et al.  Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil.  Int J Dermatol. 2002;41557-562
PubMed
Espinosa Arranz J, Sanchez Hernandez JJ, Bravo Fernandez P.  et al.  Cutaneous malignant melanoma and sun exposure in Spain.  Melanoma Res. 1999;9199-205
PubMed
Autier P, Dore JF, Schifflers E.  et al. EORTC Melanoma Cooperative Group.  Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium and France.  Int J Cancer. 1995;61749-755
PubMed
Beitner H, Norell SE, Ringborg U.  et al.  Malignant melanoma: aetiological importance of individual pigmentation and sun exposure.  Br J Dermatol. 1990;12243-51
PubMed
Graham S, Marshall J, Haughey B.  et al.  An inquiry into the epidemiology of melanoma.  Am J Epidemiol. 1985;122606-619
PubMed
Westerdahl J, Olsson H, Masback A.  et al.  Is the use of sunscreens a risk factor for malignant melanoma?  Melanoma Res. 1995;559-65
PubMed
Autier P, Dore JF.EPIMEL and EORTC (European Organization for Research and Treatment of Cancer) Melanoma Cooperative Group.  Influence of sun exposures during childhood and during adulthood on melanoma risk.  Int J Cancer. 1998;77533-537
PubMed
Naylor MF, Boyd A, Smith DW.  et al.  High sun protection factor (SPF) sunscreens in the suppression of actinic neoplasia.  Arch Dermatol. 1995;131170-175
PubMed
Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use.  N Engl J Med. 1993;3291147-1151
PubMed
Gallagher RP, Rivers JK, Lee TK.  et al.  Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial.  JAMA. 2000;2832955-2960
PubMed
Dupuy A, Dunant A, Grob J-J.Réseau d’Epidémiologie en Dermatologie.  Randomized controlled trial testing the impact of high-protection sunscreens on sun-exposure behavior.  Arch Dermatol. 2005;141950-956
PubMed
Godar DE. UV doses of American children and adolescents.  Photochem Photobiol. 2001;74787-793
PubMed
Godar DE, Urbach F, Gasparro FP, van der Leun JC. UV doses of young adults.  Photochem Photobiol. 2003;77453-457
PubMed
Robinson JK, Rigel DS, Amonette RA. Summertime sun protection used by adults for their children.  J Am Acad Dermatol. 2000;42746-753
PubMed
Feskanich D, Ma J, Fuchs CS.  et al.  Plasma vitamin D metabolites and risk of colorectal cancer in women.  Cancer Epidemiol Biomarkers Prev. 2004;131502-1508
PubMed
Munger KL, Zhang SM, O’Reilly E.  et al.  Vitamin D intake and incidence of multiple sclerosis.  Neurology. 2004;6260-65
PubMed
Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.  Am J Clin Nutr. 2004;79820-825
PubMed
Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients.  Int J Clin Pract. 2003;57258-261
PubMed
Lane NE, Gore LR, Cummings SR.  et al. Study of Osteoporotic Fractures Research Group.  Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study.  Arthritis Rheum. 1999;42854-860
PubMed
Pfeifer M, Begerow B, Minnie HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in eldery women.  J Clin Endocrinol Metab. 2001;861633-1637
PubMed
Lind L, Wengle B, Wide L, Sorensen OH, Ljunghall S. Hypertension in primary hyperparathyroidism: reduction of blood pressure by long-term treatment with vitamin D (alphcalcidol): a double-blind, placebo-controlled study.  Am J Hypertens. 1988;1(4 pt 1)  397-402
PubMed
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25 Dihydroxyvitamin D(3) is a negative endocrine regulator of the rennin-angiotensin system.  J Clin Invest. 2002;110229-238
PubMed
Dietrich T, Joshipura KJ, Dawson-Hughes B, Bischoff-Ferrari HA. Association between serum concentrations of 25-hydroxy-vitamin D3 and periodontal disease in the US population.  Am J Clin Nutr. 2004;80108-113
PubMed
John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the NHANES (National Health and Nutrition Examination Survey) I epidemiologic follow-up study, 1971-1975 to 1992.  Cancer Epidemiol Biomarkers Prev. 1999;8399-406
PubMed
Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast, colon and prostate cancer (Norway).  Cancer Causes Control. 2004;15149-158
PubMed
Standing Committee on the Scientific Evaluation of Dietary Reference Intake.  Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and FluorideWashington, DC; National Academy Press; 1997
Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents.  AJDC. 2004;158531-537
PubMed
Gilchrest BA, Cooper KD, Bischoff-Ferrari HA.  et al.  Sunlight, tanning booths, and vitamin D.  J Am Acad Dermatol. 2005;52868-876
PubMed
Rigel DS, Friedman RJ, Kopf AW, Polsky D. ABCDE: an evolving concept in the early detection of melanoma.  Arch Dermatol. 2005;1411032-1034
PubMed
Jemal A, Taylor M, Ward E.  et al.  Cancer statistics, 2005.  CA Cancer J Clin. 2005;5510-30
PubMed
Tsao H, Rogers GS, Sober AJ. An estimate of the annual direct cost of treating cutaneous melanoma and melanoma cell lines.  J Am Acad Dermatol. 1998;38669-680
PubMed
Robinson JK, Amonette R, Wyatt SW, Bewerse BA, Bergfeld WF, Farris P. Executive summary of the national ‘Sun Safety: Our Future’ conference.  J Am Acad Dermatol. 1998;38774-780
PubMed
National Institutes of Health; National Institute of Environmental Health Services; US Department of Health and Human Services National Toxicology Program.  9th annual report on carcinogens: 2001. Available at: http://ehis.niehs.nih.gov/roc. Accessed July 31, 2005
Hester EJ, Helig LF, D’Ambrosia R, Drake AL, Schilling LM, Dellavalle RP. Compliance with youth access regulations for indoor UV tanning.  Arch Dermatol. 2005;141959-962
PubMed
Hillhouse J, Turrisi R. Skin cancer risk behaviors: a conceptual framework for complex behavioral change.  Arch Dermatol. 2005;1411028-1031
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Thieden E, Philipsen PA, Sandby-Møller J, Wulf HC. Sunscreen use related to UV exposure, age, sex, and occupation based on personal dosimeter readings and sun-exposure behavior diaries.  Arch Dermatol. 2005;141967-973
PubMed
Green A, Williams G, Neale R.  et al.  Daily sunscreen application and betacarotene supplementation in prevention of basal cell and squamous cell carcinomas of the skin: a randomized controlled trial.  Lancet. 1999;354723-729
PubMed
Rodenas JM, Delgado-Rodriguez M, Herranz MT.  et al.  Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population.  Cancer Causes Control. 1996;7275-283
PubMed
Bakos L, Wagner M, Bakos RM.  et al.  Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil.  Int J Dermatol. 2002;41557-562
PubMed
Espinosa Arranz J, Sanchez Hernandez JJ, Bravo Fernandez P.  et al.  Cutaneous malignant melanoma and sun exposure in Spain.  Melanoma Res. 1999;9199-205
PubMed
Autier P, Dore JF, Schifflers E.  et al. EORTC Melanoma Cooperative Group.  Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium and France.  Int J Cancer. 1995;61749-755
PubMed
Beitner H, Norell SE, Ringborg U.  et al.  Malignant melanoma: aetiological importance of individual pigmentation and sun exposure.  Br J Dermatol. 1990;12243-51
PubMed
Graham S, Marshall J, Haughey B.  et al.  An inquiry into the epidemiology of melanoma.  Am J Epidemiol. 1985;122606-619
PubMed
Westerdahl J, Olsson H, Masback A.  et al.  Is the use of sunscreens a risk factor for malignant melanoma?  Melanoma Res. 1995;559-65
PubMed
Autier P, Dore JF.EPIMEL and EORTC (European Organization for Research and Treatment of Cancer) Melanoma Cooperative Group.  Influence of sun exposures during childhood and during adulthood on melanoma risk.  Int J Cancer. 1998;77533-537
PubMed
Naylor MF, Boyd A, Smith DW.  et al.  High sun protection factor (SPF) sunscreens in the suppression of actinic neoplasia.  Arch Dermatol. 1995;131170-175
PubMed
Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use.  N Engl J Med. 1993;3291147-1151
PubMed
Gallagher RP, Rivers JK, Lee TK.  et al.  Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial.  JAMA. 2000;2832955-2960
PubMed
Dupuy A, Dunant A, Grob J-J.Réseau d’Epidémiologie en Dermatologie.  Randomized controlled trial testing the impact of high-protection sunscreens on sun-exposure behavior.  Arch Dermatol. 2005;141950-956
PubMed
Godar DE. UV doses of American children and adolescents.  Photochem Photobiol. 2001;74787-793
PubMed
Godar DE, Urbach F, Gasparro FP, van der Leun JC. UV doses of young adults.  Photochem Photobiol. 2003;77453-457
PubMed
Robinson JK, Rigel DS, Amonette RA. Summertime sun protection used by adults for their children.  J Am Acad Dermatol. 2000;42746-753
PubMed
Feskanich D, Ma J, Fuchs CS.  et al.  Plasma vitamin D metabolites and risk of colorectal cancer in women.  Cancer Epidemiol Biomarkers Prev. 2004;131502-1508
PubMed
Munger KL, Zhang SM, O’Reilly E.  et al.  Vitamin D intake and incidence of multiple sclerosis.  Neurology. 2004;6260-65
PubMed
Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.  Am J Clin Nutr. 2004;79820-825
PubMed
Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients.  Int J Clin Pract. 2003;57258-261
PubMed
Lane NE, Gore LR, Cummings SR.  et al. Study of Osteoporotic Fractures Research Group.  Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study.  Arthritis Rheum. 1999;42854-860
PubMed
Pfeifer M, Begerow B, Minnie HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in eldery women.  J Clin Endocrinol Metab. 2001;861633-1637
PubMed
Lind L, Wengle B, Wide L, Sorensen OH, Ljunghall S. Hypertension in primary hyperparathyroidism: reduction of blood pressure by long-term treatment with vitamin D (alphcalcidol): a double-blind, placebo-controlled study.  Am J Hypertens. 1988;1(4 pt 1)  397-402
PubMed
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25 Dihydroxyvitamin D(3) is a negative endocrine regulator of the rennin-angiotensin system.  J Clin Invest. 2002;110229-238
PubMed
Dietrich T, Joshipura KJ, Dawson-Hughes B, Bischoff-Ferrari HA. Association between serum concentrations of 25-hydroxy-vitamin D3 and periodontal disease in the US population.  Am J Clin Nutr. 2004;80108-113
PubMed
John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the NHANES (National Health and Nutrition Examination Survey) I epidemiologic follow-up study, 1971-1975 to 1992.  Cancer Epidemiol Biomarkers Prev. 1999;8399-406
PubMed
Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast, colon and prostate cancer (Norway).  Cancer Causes Control. 2004;15149-158
PubMed
Standing Committee on the Scientific Evaluation of Dietary Reference Intake.  Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and FluorideWashington, DC; National Academy Press; 1997
Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents.  AJDC. 2004;158531-537
PubMed
Gilchrest BA, Cooper KD, Bischoff-Ferrari HA.  et al.  Sunlight, tanning booths, and vitamin D.  J Am Acad Dermatol. 2005;52868-876
PubMed
Rigel DS, Friedman RJ, Kopf AW, Polsky D. ABCDE: an evolving concept in the early detection of melanoma.  Arch Dermatol. 2005;1411032-1034
PubMed
Jemal A, Taylor M, Ward E.  et al.  Cancer statistics, 2005.  CA Cancer J Clin. 2005;5510-30
PubMed
Tsao H, Rogers GS, Sober AJ. An estimate of the annual direct cost of treating cutaneous melanoma and melanoma cell lines.  J Am Acad Dermatol. 1998;38669-680
PubMed
Robinson JK, Amonette R, Wyatt SW, Bewerse BA, Bergfeld WF, Farris P. Executive summary of the national ‘Sun Safety: Our Future’ conference.  J Am Acad Dermatol. 1998;38774-780
PubMed
National Institutes of Health; National Institute of Environmental Health Services; US Department of Health and Human Services National Toxicology Program.  9th annual report on carcinogens: 2001. Available at: http://ehis.niehs.nih.gov/roc. Accessed July 31, 2005
Hester EJ, Helig LF, D’Ambrosia R, Drake AL, Schilling LM, Dellavalle RP. Compliance with youth access regulations for indoor UV tanning.  Arch Dermatol. 2005;141959-962
PubMed
Hillhouse J, Turrisi R. Skin cancer risk behaviors: a conceptual framework for complex behavioral change.  Arch Dermatol. 2005;1411028-1031
PubMed
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.